Skip to content

Ardelyx ARDX Property, plant and equipment at cost

Property, plant and equipment at cost at other companies

AbbVie logo
AbbVieABBV
Aurinia Pharmaceuticals logo
Aurinia PharmaceuticalsAUPH

Other financials

Income statement

See full
Revenue$94.5M+27.5%
Gross profit$89.7M+45.1%
Operating income-$32.8M+9.8%
Net income-$37.6M+8.6%
EPS (diluted)-$0.15+11.8%

Balance sheet

See full
Cash & equivalents$31.2M+1.3%
Total debt$208.3M+34.3%
Total equity$148.6M+2.0%
Total assets$504.5M+23.0%

Cash flow

See full
Operating cash flow-$32.2M+16.2%
CapEx$69.0K-78.8%
Free cash flow-$32.3M+16.7%

Valuation

See full
Market cap$1.53B+79.5%
Enterprise value$1.71B+74.8%
P/S3.6×+1.2×

Profitability

See full
Gross margin92.5%+7.9pp
Operating margin-25.4%
Net margin-13.6%
FCF margin-40.9%

Returns & leverage

See full
Return on equity-39.5%
Debt / equity1.4×+0.3×
Current ratio3.5×-0.6×

Where this comes from

Reported directly by Ardelyx in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentGross.

The official record: Ardelyx’s 10-K, filed February 19, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ardelyx's property, plant and equipment at cost.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ardelyx's property, plant and equipment at cost?
Ardelyx (ARDX) reported property, plant and equipment at cost of $4.83M in Q4 2025.
How has Ardelyx's property, plant and equipment at cost changed year-over-year?
Ardelyx's property, plant and equipment at cost decreased by 60.1% year-over-year, from $12.11M to $4.83M.
What is the long-term trend for Ardelyx's property, plant and equipment at cost?
Over 5 years (2020 to 2025), Ardelyx's property, plant and equipment at cost has grown at a -21.7% compound annual growth rate (CAGR), from $16.39M to $4.83M.